Zanoni L.; Bezzi D.; Nanni C.; Paccagnella A.; Farina A.; Broccoli A.; Casadei B.; Zinzani P.L.; Fanti S., PET/CT in Non-Hodgkin Lymphoma: An Update, «SEMINARS IN NUCLEAR MEDICINE», 2022, S0001-2998, pp. 96 - 96 [Scientific article]
Asioli, S; Agostinelli, C; Morandi, L; Zoli, M; Mazzatenta, D; Iommi, M; Righi, S; Sabattini, E; Zinzani, Pl; Broccoli, A; Bagnato, G; Cirillo, L; Tonon, C; Lodi, R; Giannini, C, Primary Diffuse Large B-cell Lymphoma of the Central Nervous System: Unmet Medical Need, «LABORATORY INVESTIGATION», 2022, 102, pp. 1187 - 1188 [Scientific article]
Broccoli, Alessandro; Argnani, Lisa; Coppola, Paolo Elia; Gentilini, Marianna; Bagnato, Gianmarco; Lolli, Ginevra; Carella, Matteo; Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Zinzani, Pier Luigi, Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series, «TUMORI», 2022, Online ahead of print, pp. 3008916221090327 - 3008916221090327 [Scientific article]
Argnani L, Broccoli A, Pellegrini C, Fabbri A, Puccini B, Bruna R, Tisi MC, Masia F, Flenghi L, Nizzoli ME, Musso M, Salerno M, Scalzulli PR, Dessi' D, Ferrarini I, Pennese E, Lucchini E, Rossi FG, Minoia C, Gherlinzoni F, Musto P, Patti C, Stefoni V, Zinzani PL., Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy., «HEMASPHERE», 2022, 6, pp. 1 - 5 [Scientific article]Open Access
Casadei, B.; Argnani, L.; Broccoli, A.; Patti, C.; Stefani, P. M.; Cuneo, A.; Casaluci, G. M.; Visco, C.; Gini, G.; Pane, F.; D'Alo, F.; Luzi, D.; Cantonetti, M.; Pozzi, S.; Musuraca, G.; Rosignoli, C.; Arcari, A.; Kovalchuk, S.; Tani, M.; Tisi, M. C.; Petrini, M.; Stefoni, V.; Zinzani, P. L., Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study, «CANCERS», 2022, 14, Article number: 654 , pp. 1 - 11 [Scientific article]Open Access
Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L., A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. e817 - e819 [Scientific article]
Broccoli, A.; Zinzani, P. L., Emerging new small molecules in peripheral t-cell lymphomas, in: The Peripheral T‐Cell Lymphomas, New York, Wiley, 2021, pp. 343 - 349 [Chapter or essay]
Morigi A.; Stefoni V.; Argnani L.; Broccoli A.; Zinzani P.L., Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. e678 - e679 [Scientific article]
Broccoli, A.; Argnani, L.; Zinzani, P. L., Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?, «CURRENT HEMATOLOGIC MALIGNANCY REPORTS», 2021, 16, pp. 82 - 88 [Scientific article]
Broccoli A.; Argnani L.; Morigi A.; Nanni L.; Casadei B.; Pellegrini C.; Stefoni V.; Zinzani P.L., Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 5845 , pp. 5845 - 5845 [Scientific article]Open Access
Zanoni, Lucia; Mattana, Francesco; Calabrò, Diletta; Paccagnella, Andrea; Broccoli, Alessandro; Nanni, Cristina; Fanti, Stefano, Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma, «EUROPEAN JOURNAL OF RADIOLOGY», 2021, 141, pp. 109793 - 109793 [Scientific article]
Coppola P.E.; Broccoli A.; Argnani L.; Casadei B.; Stefoni V.; Bertuzzi C.; Sabattini E.; Zinzani P.L., Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 3540 - 3543 [Scientific article]
Casadei B, Argnani L, Guadagnuolo S, Pellegrini C, Stefoni V, Broccoli A, Nanni L, Morigi A, Lolli G, Guarino M, Spinardi L, Pierucci E, Fanti S, Bartoletti M, Dicataldo M, Sabattini E, Bonifazi F, Zinzani PL., Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience., «CANCERS», 2021, 13, pp. 4789 - 4789 [Scientific article]Open Access
Broccoli, A.; Argnani, L.; Nanni, L.; Terragna, C.; Sabattini, E.; Gabrielli, G.; Stefoni, V.; Pellegrini, C.; Casadei, B.; Morigi, A.; Lolli, G.; Carella, M.; Coppola, P. E.; Zinzani, P. L., The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience, «AMERICAN JOURNAL OF HEMATOLOGY», 2021, 96, pp. 1204 - 1210 [Scientific article]Open Access
Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L., Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients, «ANNALS OF HEMATOLOGY», 2021, 100, pp. 2261 - 2268 [Scientific article]Open Access
